Kamada director granted 30,000 stock options

Kamada director Leon Recanati received a grant of 30,000 employee stock options on August 5, 2026.

Rhea-AI Filing Summary

Kamada director Leon Recanati received a grant of 30,000 employee stock options on August 5, 2026. Each option permits purchase of one ordinary share at an exercise price of $7.5200 per share, presented in U.S. dollars as a convenience conversion from NIS using the Bank of Israel exchange rate as of August 4, 2026. The options, held indirectly by a trustee under Kamada's 2011 Share Award Plan, vest in four equal annual installments over four years and are exercisable for ten years from the grant date; 30,000 options were reported as held by Recanati after this award.

Insider Trade Summary

Grant/Award: 30,000 shares

Grant/Award 1 txn

Insider RECANATI LEON

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy) F1, F2, F3	30,000	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (right to buy) — 30,000 contracts (Indirect, Held by trustee)

Footnotes (3)

1. F1. The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.
2. F2. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.
3. F3. Held by trustee under the Company's 2011 Share Award Plan.

Key Figures

Options Granted: 30,000 options Exercise Price: $7.5200 per share Underlying Ordinary Shares: 30,000 shares +2 more

5 metrics

Options Granted 30,000 options Employee stock option grant to Leon Recanati on August 5, 2026

Exercise Price $7.5200 per share Exercise price presented in U.S. dollars, converted from NIS using August 4, 2026 Bank of Israel rate

Underlying Ordinary Shares 30,000 shares Each option is exercisable for one ordinary share

Vesting Period 4 years 25% of options vest on each anniversary of the grant date

Option Term 10 years Options exercisable for ten years from grant date before expiring

Key Terms

Employee Stock Option (right to buy), exercise price, vest over a period of four years, 2011 Share Award Plan

4 terms

Employee Stock Option (right to buy) financial

"Security titled "Employee Stock Option (right to buy)""

exercise price financial

"The exercise price presented in U.S. dollars represent a convenience conversion"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest over a period of four years financial

"The options will vest over a period of four years in four equal installments"

2011 Share Award Plan financial

"Held by trustee under the Company's 2011 Share Award Plan."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock option grant did Kamada (KMDA) director Leon Recanati receive?

Leon Recanati received 30,000 employee stock options on August 5, 2026. Each option covers one ordinary share with an exercise price of $7.5200 per share, reported as a convenience conversion from NIS.

What is the vesting schedule for Leon Recanati’s Kamada (KMDA) stock options?

The options vest over four years in four equal installments. 25% of the options vest on each anniversary of the grant date, until all 30,000 options are fully vested after four years.

How long are Leon Recanati’s Kamada (KMDA) options exercisable?

The options are exercisable for a period of 10 years from the grant date. Any options that remain unexercised at the end of this 10-year term will expire immediately thereafter.

How are Leon Recanati’s Kamada (KMDA) options held according to the Form 4?

The Form 4 states the options are held indirectly by a trustee under Kamada’s 2011 Share Award Plan. This means the position is reported as indirect ownership rather than directly held in his own name.

Was Leon Recanati’s Kamada (KMDA) option grant made under a Rule 10b5-1 plan?

The Form 4 indicates the Rule 10b5-1 checkbox was not selected. This means the reported grant was not identified in the filing as being made under a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/06/2026 - 07:00 AM Accepted by SEC EDGAR 08/06/2026 - 07:00 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RECANATI LEON

(Last) (First) (Middle)

2 HOLTZMAN ST.

(Street)

REHOVOT

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$7.52(1)	08/05/2026		A		30,000		(2)	(2)	Ordinary Shares	30,000	$0.00	30,000	I	Held by trustee(3)

Explanation of Responses:

1. The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.

2. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

3. Held by trustee under the Company's 2011 Share Award Plan.

	/s/ Leon Recanati	08/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)